The integrated solution in collaboration is expected to provide real-time glucose data and actionable information for diabetic patients
Image: User wearing Abbott’s world-leading FreeStyle Libre system and scanning with a smartphone. Photo: Courtesy of Abbott.
US-based medical devices provider Abbott has entered into a collaboration with Omada Health to provide integrated digital health solution for people with Type 2 diabetes.
Under the partnership, Abbott will integrate its FreeStyle Libre system with Omada’s digital coaching platform to provide personalised care for diabetic patients.
Abbott diabetes care senior vice president Jared Watkin said: “We’ve seen how FreeStyle Libre transforms lives through its proven track record in improving health outcomes, and our goal is to find new ways for even more people with diabetes to benefit from this technology.
“Through this collaboration, we’re creating a personalized care experience that combines Abbott’s leading CGM technology with Omada Health’s professional coaching and digital platform – giving people with Type 2 diabetes actionable information that leads to better health.”
The integrated digital solution for people with Type 2 diabetes
FreeStyle Libre is a sensor-based glucose monitoring system that measures glucose levels through a sensor that can be worn on the back of the upper arm, avoiding the use of fingersticks. It provides real-time glucose information with a one-second scan using a smartphone.
The integrated solution is expected to provide real-time glucose data and actionable information for diabetes patients to better manage the disease and guide personalised recommendations from the coaches.
Omada Health will offer the integrated solution and health plans to guide the eligible Type 2 diabetic patients through online physician consultation, prescription of Freestyle Libre and delivery of welcome kit comprising CGM system and wireless scale.
The solution enables participants to track progress and receive customised recommendations from the assigned certified diabetes educator (CDE) coaches through Omada’s smartphone app.
Abbott said that the integrated digital solution is designed based on its advanced algorithms and analytics, to offer personalised digital care for patients through their smartphones.
The collaboration also includes interactive educational lessons on diabetes, online peer group support and a customised action plan to build long-term healthy habits for participants.
Omada co-founder and chief executive officer Sean Duffy said: “The mission of Omada Health has always been to empower meaningful, sustainable behaviour change for those individuals living with Type 2 diabetes and other chronic conditions.
“Partnering with Abbott to give individuals access to FreeStyle Libre as part of the Omada program will deliver a unique combination of personalised human coaching and technology-enabled care to support those goals.”